Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya: protocol for a prospective

Eren Oyungu1,2, Ola El Kebbi3, Rachel Vreeman2,4

  • 1Department of Medical Physiology, Moi University College of Health Sciences, Eldoret, Kenya.

BMJ Open
|April 5, 2022
PubMed

Insights

This study identifies risk factors for neurodevelopmental outcomes in children exposed to HIV and antiretrovirals. A risk assessment tool will be developed to predict adverse outcomes in infants up to 24 months.

Area of Science:

  • Pediatric Neurodevelopment
  • HIV/AIDS Research
  • Longitudinal Cohort Studies

Background:

  • Children exposed to HIV and antiretrovirals face uncertain neurodevelopmental risks.
  • Identifying predictive factors for neurodevelopmental outcomes is crucial.

Purpose of the Study:

  • To determine risk factors predicting neurodevelopmental outcomes in children up to 24 months.
  • To develop a risk assessment tool for identifying at-risk children.

Main Methods:

  • Prospective longitudinal cohort study of 1000 infants (500 HIV-exposed, 500 unexposed) in Kenya.
  • Bi-annual measurement of infectious morbidity and biological/sociodemographic/psychosocial factors.
  • Neurodevelopmental assessment at 24 months using Child Behaviour Checklist and Bayley Scales.

Main Results:

  • Analysis will quantify associations between risk factors and neurodevelopmental outcomes.
  • A predictive risk assessment tool will be created for children up to 24 months.

Conclusions:

  • The study will elucidate key predictors of neurodevelopmental outcomes in HIV-exposed children.
  • Findings will inform targeted interventions and support for at-risk infants.
Abstract